BlackRock’s HOOKIPA Pharma HOOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,250
Closed -$15.4K 5513
2025
Q2
$15.4K Hold
12,250
﹤0.01% 5173
2025
Q1
$13.2K Hold
12,250
﹤0.01% 5145
2024
Q4
$24.6K Hold
12,250
﹤0.01% 5074
2024
Q3
$52.7K Sell
12,250
-217
-2% -$1.15K ﹤0.01% 4806
2024
Q2
$73.8K Sell
12,467
-16,462
-57% -$131K ﹤0.01% 4776
2024
Q1
$206K Sell
28,929
-498
-2% -$3.54K ﹤0.01% 4571
2023
Q4
$238K Sell
29,427
-97
-0.3% -$534 ﹤0.01% 4594
2023
Q3
$182K Buy
29,524
+3,782
+15% +$27.8K ﹤0.01% 4706
2023
Q2
$227K Sell
25,742
-8,125
-24% -$90.2K ﹤0.01% 4701
2023
Q1
$249K Buy
33,867
+358
+1% +$3.21K ﹤0.01% 4714
2022
Q4
$271K Buy
33,509
+231
+0.7% +$2.5K ﹤0.01% 4768
2022
Q3
$445K Buy
33,278
+398
+1% +$6.11K ﹤0.01% 4757
2022
Q2
$537K Sell
32,880
-83,037
-72% -$1.37M ﹤0.01% 4756
2022
Q1
$2.64M Sell
115,917
-5,333
-4% -$95.6K ﹤0.01% 4274
2021
Q4
$2.83M Buy
121,250
+15,899
+15% +$639K ﹤0.01% 4261
2021
Q3
$6.2M Buy
105,351
+299
+0.3% +$21.7K ﹤0.01% 3872
2021
Q2
$9.62M Buy
105,052
+30,673
+41% +$4.09M ﹤0.01% 3657
2021
Q1
$10M Buy
74,379
+10,096
+16% +$1.22M ﹤0.01% 3577
2020
Q4
$7.13M Buy
64,283
+1,806
+3% +$195K ﹤0.01% 3538
2020
Q3
$5.92M Buy
62,477
+3,532
+6% +$360K ﹤0.01% 3497
2020
Q2
$6.85M Buy
58,945
+12,726
+28% +$1.24M ﹤0.01% 3397
2020
Q1
$3.81M Buy
46,219
+4,993
+12% +$547K ﹤0.01% 3455
2019
Q4
$5.04M Buy
41,226
+29,153
+241% +$2.48M ﹤0.01% 3495
2019
Q3
$905K Buy
12,073
+1,120
+10% +$82.6K ﹤0.01% 4016
2019
Q2
$737K Buy
+10,953
New +$1.16M ﹤0.01% 4104

Other funds holding HOOK

BlackRock's HOOK Position: Q3 2025 in Review

BlackRock sold out of HOOKIPA Pharma (HOOK) in Q3 2025, closing a stake of 12,250 shares — an estimated $15.4K sold.

BlackRock first reported a position in HOOK in Q2 2019 and held it in 25 quarters. The position peaked at $10M in Q1 2021. 6 funds tracked by Wall St. Rank hold HOOK as of Q3 2025.

  • BlackRock reported no remaining HOOKIPA Pharma position as of Q3 2025 after selling out during the quarter.
  • BlackRock sold 12,250 HOOKIPA Pharma shares in Q3 2025, an estimated $15.4K.
  • BlackRock first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 25 quarters.
  • BlackRock's HOOKIPA Pharma position peaked at $10M in Q1 2021.
  • 6 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2025.

Based on BlackRock's 13F filing for Q3 2025, filed 12 Nov 2025.